US 9790261
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted A61PA61P35/00A61P37/02
Quick answer
US patent 9790261 (Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P35/00, A61P37/02